We previously established a mouse AML model, in which fetal liver-derived haematopoietic stem cells (HPSCs) are transformed through expression of the NUP98::KDM5A fusion oncoprotein and subsequent transplantation into recipient mice. The gene discussed is KDM5A; the disease is acute myeloid leukemia.